Legend Biotech (LEGN) News Today $34.08 +0.06 (+0.18%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Franklin Resources Inc. Buys New Position in Legend Biotech Co. (NASDAQ:LEGN)Franklin Resources Inc. purchased a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 258,396 shares of the company's stock, valued at approximatelDecember 21 at 4:46 AM | marketbeat.comBrokerages Set Legend Biotech Co. (NASDAQ:LEGN) PT at $81.54December 20 at 2:43 AM | americanbankingnews.comLegend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 19 at 8:01 AM | globenewswire.comBarclays PLC Sells 35,663 Shares of Legend Biotech Co. (NASDAQ:LEGN)Barclays PLC trimmed its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 18.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,350 shares of the company's stock after selling 35,663 sharesDecember 18 at 4:16 AM | marketbeat.comLegend Biotech (NASDAQ:LEGN) Reaches New 1-Year Low - Here's What HappenedLegend Biotech (NASDAQ:LEGN) Reaches New 1-Year Low - What's Next?December 17, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Down 5.3% - Time to Sell?Legend Biotech (NASDAQ:LEGN) Trading Down 5.3% - Here's What HappenedDecember 16, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Given Consensus Rating of "Buy" by AnalystsShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the thirteen research firms that are covering the firm, Marketbeat Ratings reports. Thirteen equities research analysts have rated the stock with a buy recommendation. The averaDecember 15, 2024 | marketbeat.comWilliam Blair Sticks to Its Hold Rating for Legend Biotech (LEGN)December 11, 2024 | markets.businessinsider.comPositive Prospects for Legend Biotech’s CARVYKTI: Buy Rating Backed by Real-World Safety Data and Competitive PositionDecember 11, 2024 | markets.businessinsider.comRoyal Bank of Canada Reiterates Outperform Rating for Legend Biotech (NASDAQ:LEGN)December 11, 2024 | americanbankingnews.comDeep Dive Into Legend Biotech Stock: Analyst Perspectives (10 Ratings)December 10, 2024 | benzinga.comLegend Biotech (NASDAQ:LEGN) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $73.00 price target on shares of Legend Biotech in a research report on Tuesday.December 10, 2024 | marketbeat.comWellington Management Group LLP Trims Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Wellington Management Group LLP trimmed its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 27.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,036,370 shares of the company's stock after selling 772,998 shares durinDecember 10, 2024 | marketbeat.comCARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple MyelomaDecember 9, 2024 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Disc Medicine (IRON) and BridgeBio Pharma (BBIO)December 9, 2024 | markets.businessinsider.comLegend Biotech (NASDAQ:LEGN) Receives "Outperform" Rating from Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and set a $86.00 price objective on shares of Legend Biotech in a report on Monday.December 9, 2024 | marketbeat.comXTX Topco Ltd Acquires Shares of 37,769 Legend Biotech Co. (NASDAQ:LEGN)XTX Topco Ltd bought a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 37,769 shares of the company's stock, valued at approximately $1,840,000. Other institutional investorDecember 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Reduces Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)Point72 Asset Management L.P. decreased its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 35.8% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 195,371 shares of the company's stock after selling 109,149 shares during the quarteDecember 8, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 93.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,859 shares of the company's stock after selling 220,200 sDecember 7, 2024 | marketbeat.comLegend Biotech: The Story BrightensDecember 5, 2024 | seekingalpha.comJanus Henderson Group PLC Lowers Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Janus Henderson Group PLC reduced its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,185,634 shares of the cDecember 5, 2024 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Has $2.45 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 61.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 50,268 shares of the company's stock after acquiriDecember 4, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by Bamco Inc. NYBamco Inc. NY reduced its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 45.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 168,158 shares of the company's stock after selling 141,106December 3, 2024 | marketbeat.comBellevue Group AG Lowers Position in Legend Biotech Co. (NASDAQ:LEGN)Bellevue Group AG cut its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 54.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 169,134 shares of the company's stock afDecember 1, 2024 | marketbeat.comBraidwell LP Lowers Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)Braidwell LP lowered its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,541,551 shares of the company's stock after selling 128,169 shNovember 29, 2024 | marketbeat.comVestal Point Capital LP Invests $6.09 Million in Legend Biotech Co. (NASDAQ:LEGN)Vestal Point Capital LP acquired a new stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 125,000 shares of the compNovember 29, 2024 | marketbeat.comFmr LLC Purchases 708,620 Shares of Legend Biotech Co. (NASDAQ:LEGN)Fmr LLC grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 4.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,330,219 shares of the company's stock after purchasing an adNovember 28, 2024 | marketbeat.comLegend Biotech (LEGN) Gets a Buy from RBC CapitalNovember 28, 2024 | markets.businessinsider.comWhy Is Legend Biotech Corp. (LEGN) Among the Best Up and Coming Stocks to Buy According to Analysts?November 28, 2024 | msn.comLegend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Westfield Capital Management Co. LPWestfield Capital Management Co. LP grew its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 5.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,038,505 shares of the company's stocNovember 24, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Purchases 314,449 Shares of Legend Biotech Co. (NASDAQ:LEGN)Massachusetts Financial Services Co. MA increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 16.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,275,158 shares of the company's stock aftNovember 24, 2024 | marketbeat.comThrivent Financial for Lutherans Grows Stake in Legend Biotech Co. (NASDAQ:LEGN)Thrivent Financial for Lutherans grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 38.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 121,377 shares of the company's stock after buying an additional 33,585 shares duNovember 24, 2024 | marketbeat.comLegend Biotech Corp. (LEGN): Among the NASDAQ Stocks with Biggest Upside Potential According to AnalystsNovember 22, 2024 | insidermonkey.comWhy Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024?November 21, 2024 | finance.yahoo.comLegend Biotech Co. (NASDAQ:LEGN) Given Consensus Recommendation of "Buy" by AnalystsShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have earned an average recommendation of "Buy" from the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a buy rating. The average 1-year target priceNovember 20, 2024 | marketbeat.comSumitomo Mitsui Trust Group Inc. Boosts Holdings in Legend Biotech Co. (NASDAQ:LEGN)Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 9.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 177,227 shares of the company's stock afNovember 18, 2024 | marketbeat.comFY2024 EPS Estimate for Legend Biotech Increased by AnalystLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Cantor Fitzgerald lifted their FY2024 earnings estimates for Legend Biotech in a research note issued to investors on Wednesday, November 13th. Cantor Fitzgerald analyst R. Bienkowski now anticipates that the company will post earnings of ($1.50) pNovember 18, 2024 | marketbeat.comLegend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts ThinkNovember 16, 2024 | finance.yahoo.comMorgan Stanley Remains a Buy on Legend Biotech (LEGN)November 16, 2024 | markets.businessinsider.comLegend Biotech (NASDAQ:LEGN) Hits New 1-Year Low - Should You Sell?Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low - Should You Sell?November 15, 2024 | marketbeat.comHC Wainwright Predicts Weaker Earnings for Legend BiotechLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities research analysts at HC Wainwright reduced their FY2024 earnings estimates for shares of Legend Biotech in a report released on Wednesday, November 13th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings ofNovember 15, 2024 | marketbeat.comFY2024 EPS Estimates for Legend Biotech Cut by William BlairLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at William Blair decreased their FY2024 earnings estimates for Legend Biotech in a research note issued to investors on Tuesday, November 12th. William Blair analyst S. Corwin now forecasts that the company will earn ($1.41) perNovember 15, 2024 | marketbeat.comLegend Biotech (LEGN) Gets a Buy from Truist FinancialNovember 14, 2024 | markets.businessinsider.comBuy Rating for Legend Biotech’s CARVYKTI: Strong Market Performance and Future PotentialNovember 14, 2024 | markets.businessinsider.comLegend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | msn.comQ2 EPS Estimates for Legend Biotech Cut by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities researchers at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of Legend Biotech in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst M. Kapoor now expects that the company will postNovember 14, 2024 | marketbeat.comLegend Biotech's (LEGN) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $73.00 price target on shares of Legend Biotech in a report on Wednesday.November 13, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Announces Earnings ResultsLegend Biotech (NASDAQ:LEGN - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.22. The business had revenue of $160.20 million during the quarter, compared to the consensus estimate of $143.91 million. Legend Biotech had a negative return on equity of 23.20% and a negative net margin of 62.50%. The business's revenue was up 66.9% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.17) earnings per share.November 13, 2024 | marketbeat.comLegend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ...November 13, 2024 | finance.yahoo.comLegend Biotech (LEGN) Gets a Hold from William BlairNovember 12, 2024 | markets.businessinsider.com Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now LEGN Media Mentions By Week LEGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.490.60▲Average Medical News Sentiment LEGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼75▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News BGNE News MRNA News VTRS News SMMT News GMAB News RDY News SRPT News CTLT News PCVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LEGN Stock Alerts